Current News
Country:
Operation:
Search for:
Overview Companies Countries Top News Tag Clouds
All   Business   Career   Cooperation   Finances   Laws   Manufacturing   Market
People   Politics   Products   Research   Technology

Contact | Print version | Send article | RSS-FeedRSS feed

Crucell Announces PER.C6® Licensing Agreement with Pfizer Animal Health

19 Mar 2007 - Crucell N.V. and Pfizer Animal Health announced the signing of a research license agreement for PER.C6®. The license agreement allows Pfizer Animal Health to use Crucell's PER.C6® cell technology in the production of a non-disclosed veterinary vaccine. Pfizer Animal Health has an option to convert the research license into a commercial agreement. Financial details were not disclosed.
 
Contact / Request Information
Additional information

Crucell N.V.
Leiden, Netherlands

Company
- Buyer's Guide entry of Crucell N.V.
 
News
- 24 Oct 2008 - Crucell Doubles Production of Quinvaxem in 2008 and Prepares Move to New Korean Production Site to Facilitate Growth
- 26 Jun 2008 - DSM and Crucell Sign Agreement with Avid Bioservices to Serve as U.S. Contract Manufacturer of PER.C6 Cell Line Proteins
- 17 Jun 2008 - DSM and Crucell Announce Record Achievement in PER.C6 Technology
 more news

Pfizer Inc.
New York, NY, United States of America

News
- 24 Nov 2008 - Stem Cell Sciences Signs Service Agreement With Pfizer to Provide Access to Proprietary Technologies and Methods
- 04 Nov 2008 - Fesoterodine approved in the U.S.
- 27 Oct 2008 - Pfizer Names New Head of Clinical Development and Medical Affairs for Its Oncology Business Unit
 more news

News regarding Business
MyBionity.COM
Newsletter Subscription
Your e-mail:
Top  
© 2001-2008 Chemie.DE Information Service GmbH
a Life Science Network Division

 www.Chemie.DE   www.Bionity.COM   www.ChemEurope.COM   www.ChemieKarriere.NET   www.BioKarriere.NET